Precision Biosciences (DTIL) Return on Sales (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Return on Sales data on file, last reported at 0.01% in Q1 2026.

• On a quarterly basis, Return on Sales rose 733.0% year-over-year to 0.01% in Q1 2026; TTM through Mar 2026 was 0.01%, a 0.0% change from a year earlier, with the FY2025 full-year figure at 0.0%, changed N/A from the prior year.
• Return on Sales for Q1 2026 stood at 0.01%, down from 0.0% in the prior quarter.
• Over the last five years, Return on Sales for DTIL reached as high as 0.0% in Q4 2025 and fell as low as 21.27% in Q3 2025.
• Historically, Return on Sales has averaged 2.47% across 5 years, with a median of 0.01% in 2022.
• Across the five-year window, Return on Sales sank 2075 bps in 2025 and jumped 733 bps in 2026, its largest moves.
• Year by year, Return on Sales stood at 0.01% in 2022, then surged by 53 bps to 0.0% in 2023, then tumbled by 9115 bps to 0.37% in 2024, then jumped by 101 bps to 0.0% in 2025, then slumped by 318 bps to 0.01% in 2026.
• Per Business Quant data, the three most recent Return on Sales figures were 0.01% in Q1 2026, 0.0% in Q4 2025, and 21.27% in Q3 2025.